Sign in

CIK 0000894158

  • Non-accelerated filer
  • Smaller reporting company

Theriva Biologics, Inc.

Sign in to watch
Ticker
TOVX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
133808303
Phone
+1 734-332-7800
Business address
9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
Former names
Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-05 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options (right to buy) +475,000 475,000
2025-04-29 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options (right to buy) +190,000 190,000
2023-12-14 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options (right to buy) +700,000 700,000
2023-06-07 SHALLCROSS STEVEN A CEO and CFO Purchase +14,000 $0.69 $10K 250,000
2023-06-06 SHALLCROSS STEVEN A CEO and CFO Purchase +26,000 $0.63 $16K 236,000
2023-02-10 SHALLCROSS STEVEN A CEO and CFO Purchase +25,000 $1.04 $26K 210,000
2023-02-02 SHALLCROSS STEVEN A CEO and CFO Purchase +25,000 $0.94 $24K 185,000
2023-01-25 SHALLCROSS STEVEN A CEO and CFO Purchase +25,000 $0.87 $22K 160,000
2023-01-20 SHALLCROSS STEVEN A CEO and CFO Purchase +25,000 $0.75 $19K 135,000
2022-12-29 SHALLCROSS STEVEN A CEO and CFO Purchase +100,000 $0.44 $44K 110,000
2022-12-15 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options (right to buy) +475,000 475,000
2021-12-23 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options (right to buy) +650,000 650,000
2021-05-10 SHALLCROSS STEVEN A CEO and CFO Purchase +50,000 $0.49 $25K 100,000
2020-12-30 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options +450,000 450,000
2019-12-04 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options +450,000 450,000
2019-08-23 SHALLCROSS STEVEN A CEO and CFO Purchase +50,000 $0.42 $21K 50,000
2018-12-06 SHALLCROSS STEVEN A CEO and CFO Grant or award · Stock Options +200,000 200,000
2017-12-20 SHALLCROSS STEVEN A Interim CEO and CFO Grant or award · Stock Options +550,000 550,000
2016-11-30 SHALLCROSS STEVEN A Chief Financial Officer Grant or award · Stock Options +500,000 500,000
2015-12-04 SHALLCROSS STEVEN A Chief Financial Officer Grant or award · Stock Options +100,000 100,000

Page 1 of 2 · 21 trades